| Home | E-Submission | Sitemap | Editorial Office |  
top_img
    
SPECIAL ARTICLE 2022 December 16
Top Ten Lessons Learned from Trials in Oligometastatic Cancers
Recent evidence supports the role of aggressive local treatment in the oligometastatic setting. In this review, we discuss the top 10 lessons we have learned from trials in oligometastatic cancers. Major lessons learned pertain to definitions of oligometastatic disease, outcomes...
ORIGINAL ARTICLE 2022 March 22
Adherence to Cancer Prevention Guidelines and Cancer Incidence and Mortality: A Population-Based Cohort Study
Purpose This study aimed to estimate the risk of cancer incidence and mortality according to adherence to lifestyle-related cancer prevention guidelines. Materials and Methods Men and women who participated in the general health screening program in 2002 and 2003 provided by th...
ORIGINAL ARTICLE 2022 February 10
Interlaboratory Comparison Study (Ring Test) of Next-Generation Sequencing–Based NTRK Fusion Detection in South Korea
Purpose Tropomyosin receptor kinase (TRK) inhibitors are approved for the treatment of neurotrophic receptor tyrosine kinase (NTRK) fusion-positive tumors. The detection of NTRK fusion using a validated method is required before therapeutic application. An interlaboratory compar...
ORIGINAL ARTICLE 2022 March 4
Suggestions for Escaping the Dark Ages for Pediatric Diffuse Intrinsic Pontine Glioma Treated with Radiotherapy: Analysis of Prognostic Factors from the National Multicenter Study
Purpose This multicenter retrospective study aimed to investigate clinical, radiologic, and treatment-related factors affecting survival in patients with newly diagnosed diffuse intrinsic pontine glioma (DIPG) treated with radiotherapy. Materials and Methods Patients aged
Current Issue
Volume 55(1); Jan 2023
Volume 54(4); October 2022
Volume 54(3); July 2022
RSS feed
  • Most-read are based on citations from 2021 ~ 2023.
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018 ( 12330 times )
    Seri Hong, Young-Joo Won, Jae Jun Lee, Kyu-Won Jung, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2021;53(2):301-315.   Published online March 17, 2021    DOI: https://doi.org/10.4143/crt.2021.291
                                  Supplementary         Cited By 141
    Prediction of Cancer Incidence and Mortality in Korea, 2021 ( 8576 times )
    Kyu-Won Jung, Young-Joo Won, Seri Hong, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
    Cancer Res Treat. 2021;53(2):316-322.   Published online March 17, 2021    DOI: https://doi.org/10.4143/crt.2021.290
                                     Cited By 36
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019 ( 7956 times )
    Mee Joo Kang, Young-Joo Won, Jae Jun Lee, Kyu-Won Jung, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2022;54(2):330-344.   Published online March 16, 2022    DOI: https://doi.org/10.4143/crt.2022.128
                                  Supplementary         Cited By 47
    Basic
    TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis ( 7194 times )
    Kyungsoo Jung, Joon-Seok Choi, Beom-Mo Koo, Yu Jin Kim, Ji-Young Song, Minjung Sung, Eun Sol Chang, Ka-Won Noh, Sungbin An, Mi-Sook Lee, Kyoung Song, Hannah Lee, Ryong Nam Kim, Young Kee Shin, Doo-Yi Oh, Yoon-La Choi
    Cancer Res Treat. 2021;53(1):9-24.   Published online September 16, 2020    DOI: https://doi.org/10.4143/crt.2020.434
                                  Supplementary         Cited By 6
    Practical Advice for South Korean Medical Researchers Regarding Open-Access and Predatory Journals ( 6790 times )
    Chai Hong Rim
    Cancer Res Treat. 2021;53(1):1-8.   Published online September 21, 2020    DOI: https://doi.org/10.4143/crt.2020.816
                                  Supplementary      
    Breast Cancer
    Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer ( 6656 times )
    Erwin Danil Yulian, Nurjati Chairani Siregar, Bajuadji
    Cancer Res Treat. 2021;53(4):1072-1083.   Published online March 9, 2021    DOI: https://doi.org/10.4143/crt.2020.1024
                                     Cited By 7
    Immunotherapy
    The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients ( 6509 times )
    Si-Qi Tang, Ling-Long Tang, Yan-Ping Mao, Wen-Fei Li, Lei Chen, Yuan Zhang, Ying Guo, Qing Liu, Ying Sun, Cheng Xu, Jun Ma
    Cancer Res Treat. 2021;53(2):339-354.   Published online November 6, 2020    DOI: https://doi.org/10.4143/crt.2020.790
                                  Supplementary         Cited By 28
    Gastrointestinal cancer
    Clinical Application of Targeted Deep Sequencing in Metastatic Colorectal Cancer Patients: Actionable Genomic Alteration in K-MASTER Project ( 6192 times )
    Youngwoo Lee, Soohyeon Lee, Jae Sook Sung, Hee-Joon Chung, Ah-reum Lim, Ju Won Kim, Yoon Ji Choi, Kyong Hwa Park, Yeul Hong Kim
    Cancer Res Treat. 2021;53(1):123-130.   Published online August 18, 2020    DOI: https://doi.org/10.4143/crt.2020.559
                                  Supplementary         Cited By 8
    Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion ( 6085 times )
    Changhoon Yoo, Chung Ryul Oh, Seung-Tae Kim, Woo Kyun Bae, Hye-Jin Choi, Do-Youn Oh, Myung-Ah Lee, Baek-Yeol Ryoo
    Cancer Res Treat. 2021;53(2):291-300.   Published online December 29, 2020    DOI: https://doi.org/10.4143/crt.2020.1233
                                     Cited By 4
    Gastrointestinal cancer
    Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells ( 6071 times )
    Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Pam Collier, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Brinda Balasubramanian, Simran Venkatraman, Isioma U. Egbuniwe, Dhanwant Gomez, Abhik Mukherjee, Supeecha Kumkate, Tavan Janvilisri, Abed M Zaitoun, Thiti Kuakpaetoon, Rutaiwan Tohtong, Anna M Grabowska, David O. Bates, Kanokpan Wongprasert
    Cancer Res Treat. 2021;53(2):457-470.   Published online October 7, 2020    DOI: https://doi.org/10.4143/crt.2020.585
                                  Supplementary         Cited By 4
    Korean Cancer Association
    E-Submission
    EndNote Output Style
    Email Alert
    Impact factor
    SCImago Journal & Country Rank
    PubMed Central
    MEDLINE/PubMed
    Scopus
    KoreaMed
    KoMCI
    ScienceCentral
    GoogleScholar
    Similarity Check
    Crossref Cited-by Linking
    CrossMark
    Funder Registry
    Metadata
    ORCID
    COPE
    Editorial Office
    Korean Cancer Association
    Room 1824, Gwanghwamun Officia
    92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
    TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © Korean Cancer Association.                 Developed in M2PI